Skip to main content

Table 5 Multifactorial analysis - Weibull Hazard Models for main effects and 2-way interactions. (Likelihood Ratios are calculated in comparison with the main effects model in Table 5)

From: Young patients with colorectal cancer have poor survival in the first twenty months after operation and predictable survival in the medium and long-term: Analysis of survival and prognostic markers

Model

Type III Analysis of Effects

Log Likelihood

p (Likelihood Ratio)

1

Factors

p

  
 

Neoadjuvant therapy (D)

0.0062

-44.301

0.1568

 

Resection Margin positivity (R)

0.0324

  
 

AJCC Stage IV vs. III or less (S)

0.2256

  
 

D*R

0.1649

  

2

Neoadjuvant therapy (D)

0.0569

-45.294

0.8933

 

Resection Margin positivity (R)

0.5757

  
 

AJCC Stage IV vs. III or less (S)

0.1435

  
 

R*S

0.8890

  

3

Neoadjuvant therapy (D)

0.6231

-45.294

0.8933

 

Resection Margin positivity (R)

0.1646

  
 

AJCC Stage IV vs. III or less (S)

0.1423

  
 

D*S

0.8890

  

4

Neoadjuvant therapy (D)

0.0955

-44.232

0.5434

 

Resection Margin positivity (R)

0.0974

  
 

AJCC Stage IV vs. III or less (S)

0.1856

  
 

D*R

0.1522

  
 

R*S

-

  
 

S*D

-

 Â